Akeso, Summit's ivonescimab delayed progression of certain lung cancers in first global phase 3 readout

fiercepharma.com/pharma/akeso-summits-ivonescimab-delayed-progression-48-certain-lung-cancers-first-global-phase-3

This story appeared on fiercepharma.com, 2025-06-01 01:35:56.875000.
The Entire Business World on a Single Page. Free to Use →